Clinical Trial

A Randomized Controlled Study of Endoscopic Cryoablation Combined With PD-1 Inhibitor for Maintenance Therapy in Advanced Gastric Cancer

Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated May 6, 2025 (before its estimated May 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study evaluates the safety and efficacy of endoscopic cryoballoon ablation treatment (ECAT) combined with a PD-1 inhibitor (sintilimab) as maintenance therapy in patients with advanced gastric cancer, and further explores the underlying immunoregulatory mechanisms.
Trial Details
NCT Number NCT06957977
Lead Sponsor Zhongguang Luo, MD
Conditions Gastric Cancer, Cryoballoon Ablation
Enrollment 42 participants
Start Date 2025-05-01
Primary Completion 2026-05-01 (estimated)
Study Completion 2027-05-01 (estimated)
Updated on ClinicalTrials.gov 2025-05-06